Vivolux AB   Report issue

For profit Phase 1 Phase 2
Founded: Uppsala Sweden (2006)
Status: Left NME R&D (2020)

Organization Overview

First Clinical Trial
2014
NCT02222363
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now